Editor’s note: Our understanding of COVID-19 symptomatology is evolving as the current pandemic unfolds. The International Society on Thrombosis and Haemostasis has collected a number of studies and case reports on thrombosis in COVID-19 patients. The Journal of American College of Cardiology released a review of current understanding, citing many of the studies and case reports which are on the ISTH site. This COVID-19 pandemic challenges us to use current knowledge and innovate new approaches to care for patients diagnosed with COVID-19. This article seeks to summarize some of the current knowledge about thrombosis in COVID-19 patients, knowing that future studies and case reports will undoubtedly refine the statements made below. However, this is science, continually evolving and improving based on current understanding. With that, this article offers some insights about VTE in patients admitted to the hospital who have been diagnosed with COVID-19.
By Michael Wong (Founder/Executive Director, Physician-Patient Alliance for Health & Safety), Laurie Paletz, BSN PHN RN BC SCRN (Manager, Stroke Program Department of Neurology, Cedars-Sinai), and Thereza B. Ayad, RN, MSN, DNP, CNOR (Assistant Professor, University of Massachusetts Medical School-Graduate School of Nursing; Surgical Services Clinical Staff Educator, North Shore Medical Center)
(reviewed by Sue Koob, MPA, Chief Executive Officer, Preventive Cardiovascular Nurses Association and Pat Salber, MD, MBA, Editor-in-Chief, DoctorWeighsIn)